1-3 of 3
Lini N. Pandite
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

HLA-B*57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients with Cancer

Chun-Fang Xu, Toby Johnson, Xiaojing Wang, Chris Carpenter, Alan P. Graves, Liling Warren, Zhengyu Xue, Karen S. King, Dana J. Fraser, Sandy Stinnett, Linda P. Briley, Ionel Mitrica, Colin F. Spraggs, Matthew R. Nelson, Hiroomi Tada, Andreas du Bois, Thomas Powles, Neil Kaplowitz, Lini N. Pandite
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (6): 1371–1377.
https://doi.org/10.1158/1078-0432.CCR-15-2044
Published: 14 March 2016
View article titled, <em>HLA-B</em>*57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients with Cancer
Open the PDF for <em>HLA-B</em>*57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients with Cancer in another window
Includes: Supplementary data
Journal Articles

Identification of a Variant in KDR Associated with Serum VEGFR2 and Pharmacodynamics of Pazopanib

Michael L. Maitland, Chun-Fang Xu, Yu-Ching Cheng, Emily Kistner-Griffin, Kathleen A. Ryan, Theodore G. Karrison, Soma Das, Dara Torgerson, Eric R. Gamazon, Vasiliki Thomeas, Matthew R. Levine, Paul A. Wilson, Nan Bing, Yuan Liu, Lon R. Cardon, Lini N. Pandite, Jeffrey R. O'Connell, Nancy J. Cox, Braxton D. Mitchell, Mark J. Ratain, Alan R. Shuldiner
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (2): 365–372.
https://doi.org/10.1158/1078-0432.CCR-14-1683
Published: 14 January 2015
View article titled, Identification of a Variant in <em>KDR</em> Associated with Serum VEGFR2 and Pharmacodynamics of Pazopanib
Open the PDF for Identification of a Variant in <em>KDR</em> Associated with Serum VEGFR2 and Pharmacodynamics of Pazopanib in another window
Includes: Supplementary data
Journal Articles

Clinical and Biological Effects of Recombinant Human Interleukin-18 Administered by Intravenous Infusion to Patients with Advanced Cancer

Michael J. Robertson, James W. Mier, Theodore Logan, Michael Atkins, Henry Koon, Kevin M. Koch, Steven Kathman, Lini N. Pandite, Coreen Oei, Lyndon C. Kirby, Roxanne C. Jewell, William N. Bell, Linda M. Thurmond, Jill Weisenbach, Suzanne Roberts, Mohammed M. Dar
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (14): 4265–4273.
https://doi.org/10.1158/1078-0432.CCR-06-0121
Published: 20 July 2006
View article titled, Clinical and Biological Effects of Recombinant Human Interleukin-18 Administered by Intravenous Infusion to Patients with Advanced Cancer
Open the PDF for Clinical and Biological Effects of Recombinant Human Interleukin-18 Administered by Intravenous Infusion to Patients with Advanced Cancer in another window